versatility of 18β-glycyrrhetinic acid in attenuating pulmonary inflammatory disorders

• Mohamad Siddiq Bin Mohamad,
• Ruby-Jean Reyes,
• Gabriele De Rubis,
• Keshav Raj Paudel,
• Philip Michael Hansbro,
• Kamal Dua,
• Dinesh Kumar Chellappan

Affiliations

Mohamad Siddiq Bin Mohamad

ORCiD

School of Postgraduate Studies, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia; Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, Australia

Ruby-Jean Reyes

ORCiD

Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia

Gabriele De Rubis

ORCiD

Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia

Keshav Raj Paudel

ORCiD

Center of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney 2007, Australia

Philip Michael Hansbro

ORCiD

Center of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney 2007, Australia

Kamal Dua

ORCiD

Faculty of Health, Australian Research Center in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia; Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun 248007, India

Dinesh Kumar Chellappan

ORCiD

Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia. E-mail: [email protected]